Figure 4.

Serum concentrations of high sensitivity C-reactive protein (hs-CRP) from baseline to day 31 (safety follow up). SC, subcutaneous.

Terkeltaub et al. Arthritis Research & Therapy 2013 15:R25   doi:10.1186/ar4159
Download authors' original image